scholarly article | Q13442814 |
P50 | author | Michael Sharpe | Q19586070 |
Keith Matthews | Q37651906 | ||
Jon Stone | Q37839943 | ||
Gordon Murray | Q42883581 | ||
P2093 | author name string | R Roberts | |
C Hansen | |||
C Warlow | |||
J Cavanagh | |||
R Duncan | |||
R Coleman | |||
A Carson | |||
A Pelosi | |||
R Goldbeck | |||
C Hibberd | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 810-813 | |
P577 | publication date | 2011-01-21 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. | |
P478 | volume | 82 |
Q41842170 | 5-HT2A Agonists: A Novel Therapy for Functional Neurological Disorders? |
Q47554844 | A case series of Acceptance and Commitment Therapy (ACT) for reducing symptom interference in functional neurological disorders |
Q48080346 | CBT-based group therapy intervention for nonepileptic attacks and other functional neurological symptoms: a pilot study |
Q47552322 | Changes in Emotion Processing following Brief Augmented Psychodynamic Interpersonal Therapy for Functional Neurological Symptoms. |
Q64355333 | Characteristics of patients with motor functional neurological disorder in a large UK mental health service: a case–control study |
Q33569750 | Closing the Major Gap in PNES Research: Finding a Home for a Borderland Disorder |
Q92685185 | Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report |
Q39940372 | Early intervention for conversion disorder: neurologists and psychiatrists working together. |
Q38248624 | Effort, symptom validity testing, performance validity testing and traumatic brain injury |
Q37984921 | Functional (psychogenic) movement disorders: merging mind and brain |
Q90381202 | Functional Cognitive Disorder: Diagnostic Challenges and Future Directions |
Q90263131 | Functional Movement Disorders and Placebo: A Brief Review of the Placebo Effect in Movement Disorders and Ethical Considerations for Placebo Therapy |
Q91302033 | Functional cognitive disorders: a systematic review |
Q34777920 | Functional disorders in the Neurology section of ICD-11: A landmark opportunity |
Q57053909 | Functional neurological disorders: acute presentations and management |
Q38593845 | Functional neurological disorders: mechanisms and treatment |
Q38087609 | Functional neurological symptoms. |
Q42654893 | Identifying motor functional neurological disorder using resting-state functional connectivity |
Q30446926 | Imaging psychogenic movement disorders |
Q41050265 | Impact of Transcranial Magnetic Stimulation on Functional Movement Disorders: Cortical Modulation or a Behavioral Effect? |
Q44031092 | Long-term satisfaction after neurological second opinions and tertiary referrals |
Q55288523 | Management of somatic symptom disorder. |
Q89519328 | Medically Unexplained Physical Symptoms: What They Are and Why Counseling Psychologists Should Care about Them |
Q38184851 | Neurology is psychiatry--and vice versa. |
Q26749987 | Non-Invasive Brain Stimulation in Conversion (Functional) Weakness and Paralysis: A Systematic Review and Future Perspectives |
Q91057157 | Nonepileptic seizures in individuals attending neurological services in New Zealand |
Q47951751 | Occupational therapy for functional neurological disorders: a scoping review and agenda for research |
Q92261830 | Physicians' gender bias in the diagnostic assessment of medically unexplained symptoms and its effect on patient-physician relations |
Q30667748 | Physiotherapy for functional motor disorders: a consensus recommendation |
Q34523004 | Psychogenic movement disorders. |
Q50637555 | Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. |
Q92209351 | The misdiagnosis of functional disorders as other neurological conditions |
Q92562228 | The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program |
Q38136849 | The prognosis of functional (psychogenic) motor symptoms: a systematic review |
Q34238492 | The role of alexithymia in the development of functional motor symptoms (conversion disorder). |
Q50248175 | Treatment of functional motor disorders |
Q48444253 | Unexplained dizziness does not resolve in time |
Search more.